Covid Patients’ Genomes to Be Analyzed in U.K. Severity Study

(Bloomberg) -- Thousands of U.K. coronavirus patients will have their genomes sequenced as part of a scientific push to determine who’s most vulnerable to the virus’s deadliest symptoms and why.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.